Cite
HARVARD Citation
Troya, J. et al. (2017). Infliximab Biosimilars: A Promising but Unusual Treatment for Mycobacterial Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients. Open forum infectious diseases. p. . [Online].